missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Bevacizumab Chimeric Recombinant Mouse Monoclonal Antibody (Bevacizumab)
GREENER_CHOICE

Mouse Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA551653

Catalog No. MA551653


Only null left

Description

Description

This antibody binds native and reduced human VEGF (isoform 165).

Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As angiogenesis inhibitor, Bevacizumab blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A).
Specifications

Chemical Identifiers

Bevacizumab Chimeric
1 mg/mL
ELISA, Flow Cytometry, Inhibition Assays, Immunoprecipitation, Western Blot
Unconjugated
Mouse
RUO
PBS with 0.02% ProClin 300
Recombinant human VEGF.
Antibody
Bevacizumab
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Recombinant Monoclonal
Liquid
IgG2a κ
Human
Avastin
Primary
Protein A

Specifications

Bevacizumab Chimeric
Recombinant Monoclonal
1 mg/mL
PBS with 0.02% ProClin 300
Mouse
Protein A
RUO
Human
Antibody
IgG2a κ
ELISA, Flow Cytometry, Inhibition Assays, Immunoprecipitation, Western Blot
Bevacizumab
Unconjugated
Avastin
Recombinant human VEGF.
200 μg
Primary
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Promotions

Promotions